Insider Trading & Ownership of Eyal C. Attar

Location: Boston, MA
Summary: The estimated net worth of Eyal C. Attar is at least $391K dollars as of February 18, 2025. Eyal C. Attar is the SVP, Chief Medical Officer, Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $211K. Eyal C. Attar is the CHIEF MEDICAL OFFICER of Vor Biopharma Inc. and owns shares of Vor Biopharma Inc. (VOR) stock worth about $180K.
Signature: /s/ Katie Kazem, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Eyal C. Attar files a new Insider Trading report.

Ownership of Eyal C. Attar

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
APRE	Aprea Therapeutics, Inc.	SVP, Chief Medical Officer, Director	$211K			Jun 3, 2022
VOR	Vor Biopharma Inc.	Chief Medical Officer	$180K	-$19.6K	-9.82%	Feb 13, 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.